ELUT

Elutia (ELUT)

Elutia Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELUT

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/06/17	21 : 30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ELUT	Elutia Inc
2024/06/17	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/06/17	21 : 01	GlobeNewswire Inc.	Elutia Announces $13.26 Million Registered Direct Offering	NASDAQ:ELUT	Elutia Inc
2024/06/17	21 : 00	GlobeNewswire Inc.	Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators	NASDAQ:ELUT	Elutia Inc
2024/06/11	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
2024/06/11	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
2024/06/11	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
2024/06/08	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/05/14	06 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELUT	Elutia Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024	NASDAQ:ELUT	Elutia Inc
2024/05/10	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/05/10	05 : 05	GlobeNewswire Inc.	Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance	NASDAQ:ELUT	Elutia Inc
2024/05/03	05 : 05	GlobeNewswire Inc.	Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	NASDAQ:ELUT	Elutia Inc
2024/04/25	05 : 05	GlobeNewswire Inc.	Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1	NASDAQ:ELUT	Elutia Inc
2024/03/11	22 : 15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ELUT	Elutia Inc
2024/03/08	06 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/03/08	06 : 05	GlobeNewswire Inc.	Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024	NASDAQ:ELUT	Elutia Inc
2024/02/23	06 : 05	GlobeNewswire Inc.	Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024	NASDAQ:ELUT	Elutia Inc
2024/02/15	06 : 40	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELUT	Elutia Inc
2024/02/03	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/01/26	06 : 56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ELUT	Elutia Inc
2024/01/13	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/01/11	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2024/01/11	06 : 05	GlobeNewswire Inc.	Elutia Regains Compliance with Nasdaq Listing Requirements	NASDAQ:ELUT	Elutia Inc
2024/01/10	06 : 17	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ELUT	Elutia Inc
2024/01/09	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELUT	Elutia Inc
2023/12/28	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc
2023/12/18	22 : 00	GlobeNewswire Inc.	Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance	NASDAQ:ELUT	Elutia Inc
2023/12/09	06 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELUT	Elutia Inc